🔎 Trials Near Me

Pradžia › ŽPV › Texas

ŽPV klinikiniai tyrimai Texas

6 tyrimai dėl ŽPV ieško dalyvių vietose Texas.

Miestai Texas

Oficialus tyrimo tekstas (anglų kalba)

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)

  • University of Texas Medical Branch, Galveston
Renkami dalyviai4 fazėLaukiami sveiki savanoriaiNurodytas atlygis dalyviams
Amžius nuo 27 iki 45 · Moterims · Atnaujinta 2026-09-15 · NCT05672927

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

  • The University of Texas, MD Anderson Cancer Center, Houston
  • UT Health Mays Cancer Center, San Antonio
Renkami dalyviai1/2 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-11 · NCT05592626

Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)

  • UT MD Anderson Cancer Center, Houston
Renkami dalyviaiLaukiami sveiki savanoriai
Amžius 25 ir vyresni · Moterims · Atnaujinta 2026-07-31 · NCT07281430

Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents

  • The University of Texas Health Science Center at Houston, Houston
Renkami dalyviai
Amžius nuo 11 iki 17 · Visoms lytims · Atnaujinta 2026-05-04 · NCT06598475

Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)

  • The Harris Health System (L.B.J Hospital), Houston
  • University of Texas, M.D. Anderson, Houston
Renkami dalyviai2 fazė
Amžius nuo 25 iki 100 · Moterims · Atnaujinta 2025-10-02 · NCT04098744

HPV Vaccine, Imiquimod, and Metformin Combination Trial

  • Baylor St. Luke's Medical Center- Dan L. Duncan Comprehensive Cancer Center, Houston
  • Harris Health Smith Clinic, Houston
Renkami dalyviai2 fazė
Amžius nuo 18 iki 64 · Moterims · Atnaujinta 2024-11-13 · NCT06686043

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.